Navigation Links
Boulder iQ Details 4 Key Regulations Medical Devices Manufacturers Must Act On Now
Date:11/3/2018

As 2018 comes to a close, significant changes to medical device regulations in the European Union (EU) continue to alter the landscape of quality systems for manufacturers worldwide. To mark World Quality Day this month, Boulder iQ outlines four key changes medical device makers must act on now.

“While 2020 may sound far off, the May 26 deadline transition deadline that year for the new Medical Device Regulation in the EU requires medical device manufacturers to take specific actions immediately,” says Carrie Hetrick, vice president of regulatory and clinical affairs at Boulder iQ, an expert consulting firm specializing in regulatory, quality and clinical compliance services for medical device and in-vitro diagnostic companies.

Among the many changes manufacturers will face, following are some of those requiring immediate attention, says Hetrick.

1.    Increased scrutiny on clinical evaluation reports (CERs) – Devices equivalence arguments may be more difficult to make, and may be more frequently challenged by notified bodies. Companies must show that their device has the same technical, biological and clinical characteristics, and demonstrate sufficient access to the data on the equivalent device. Then, says Hetrick, updates to CERs may also trigger updates to use instructions.

2.    New requirements for clinical investigations – Manufacturers will need to conduct these investigations according to the new legislation and recognized ethical principles, as well as be in sync with the clinical evaluation plan.

3.    Stepped-up activity for post-market clinical follow-up (PMCF) – Notified Bodies will look for current, active PMCF reports and plans.

4.    Increased frequency of safety and clinical performance summaries – The new regulations stipulate these must be updated yearly, at a minimum.

Because all companies that sell their devices in the EU must meet the MDR – as well as other requirements affecting quality systems, classification rules and technical documentation – the demand for expertise and help navigating the maze is significant, and growing, says Hetrick. “We are already seeing the bottleneck the new regulations are creating. Many medical device manufacturers are not equipped to handle all of the changes internally, and will need to look for additional implementation expertise, or risk orphaned devices.” Some requirements will extend beyond 2020, she adds, making it even more necessary for medical device manufacturers to find a quality systems expert with whom to partner.

About Boulder iQ (http://www.boulderiq.com)
Boulder iQ is an expert contract consulting firm for medical device and industrial product design and development. Formed as a merger between Boulder BioMed and Samson Design Associates Inc., Boulder iQ offers regulatory, quality and clinical compliance services for medical device and in-vitro diagnostic companies, and design, development and manufacturing for medical device, consumer and industrial products.

(end)

Read the full story at https://www.prweb.com/releases/boulder_iq_details_4_key_regulations_medical_devices_manufacturers_must_act_on_now/prweb15885718.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. CU-Boulder study paved way for stocking states true greenback cutthroat into wild
2. Natural-terrain schoolyards reduce childrens stress, says Colorado University-Boulder study
3. CU-Boulder, NCAR researchers seek to reduce deadly air pollution from cooking emissions
4. Novel antioxidant makes old arteries seem young again, CU-Boulder study finds
5. Neanderthals were not inferior to modern humans, says CU-Boulder study
6. Bright pulses of light could make space veggies more nutritious, says CU-Boulder study
7. Methane leaks from palm oil wastewater are a climate concern, CU-Boulder study says
8. Still-fresh remnants of Exxon Valdez oil protected by boulders
9. CU-Boulder stem cell research may point to new ways of mitigating muscle loss
10. CU-Boulder researchers sequence worlds first butterfly bacteria, find surprises
11. New CU-Boulder study shows differences in mammal responses to climate change
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/11/2019)... ... 2019 , ... Improved Pharma LLC announces the publication of “Predictive and Accelerated ... article was published online on April 29th, 2019. The authors are Stephen R. ... of Purdue University. , The article is the most recent addition to a theme ...
(Date:6/6/2019)... , ... June 05, 2019 , ... ... the opening of a new network station and service center in Mexico City, ... 12th in the world — with more than $1.75 billion in pharmaceutical exports ...
(Date:6/4/2019)... ... June 04, 2019 , ... In’Tech ... devices, today announced Q1-19 revenues of $31M, up 12% from Q1-18. The growth ... of strategic investments & operational excellence initiatives worldwide. , Laurent Pruvost , ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 10, 2019 , ... ... in an upcoming episode, scheduled to broadcast 4Q/2019. Check your local listings for ... will educate viewers about how its technology facilitates laboratories to improve efficiency and ...
(Date:6/6/2019)... ... June 05, 2019 , ... WCCT Global, Inc ., ... industries, announced today that they will be receiving 3 awards at the 2019 CRO ... received 2 awards in the categories of overall Quality and Compatibility (Access to desired ...
(Date:5/31/2019)... DURHAM, N.C. (PRWEB) , ... May 30, 2019 ... ... Medicine is the first to demonstrate an efficient delivery system for the sustained ... kidney injuries. The platelet-rich plasma-based gel system was able to deliver CM into ...
(Date:5/14/2019)... N.J. (PRWEB) , ... May 13, 2019 , ... ... custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and ... Heliumleak.com company website. The redesigned website aims to improve LDA’s ability to communicate ...
Breaking Biology Technology: